Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating eye disorders with APLNR antagonists and VEGF inhibitors

Methods of treating eye disorders with APLNR antagonists and VEGF inhibitors

US Patent 11104730 · Granted Aug 31, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Non-human animals models of retinoschisis2024
Method of treatment with a fusion protein comprising apelin and an anti-APLNR an2023
Humanized C5 animals2021
Methods and formulations for treating vascular eye diseases using aflibercept an2021
Methods and formulations for treating vascular eye diseases using aflibercept an2021
Non-human animal models of retinoschisis2021
Fusion protein comprising apelin and an anti-APLNR antibody2021
Method for treating pathological angiogenesis by administering an antibody that 2020
Humanized C3 animals2020
Humanized C5 animals2019
Methods for improving cardiac function by administering an antibody that activat2019
APLNR modulators and uses thereof2018